药物警戒和药物安全软体市场规模、份额和成长分析（按功能、部署模式、最终用户和地区划分）—产业预测，2026-2033年

Pharmacovigilance and Drug Safety Software Market Size, Share, and Growth Analysis, By Functionality (Adverse Event Reporting Software, Drug Safety Audits Software), By Deployment Mode, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 207 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，药物警戒和药物安全软体市场规模将达到 2.1473 亿美元，到 2025 年将达到 2.3728 亿美元，到 2033 年将达到 5.2743 亿美元，在预测期（2026-2033 年）内复合增长率为 10.5%。

全球药物警戒和药物安全软体市场正在不断发展，旨在加强对不利事件(ADR) 及相关安全问题的追踪、分析和报告。在罗马尼亚，这些软体解决方案透过监测药物疗效和副作用，在确保药物安全有效使用方面发挥关键作用。它们使製药公司、监管机构和医疗保健专业人员能够有效地收集、管理和分析各种药物安全数据，识别潜在风险和趋势，并促进及时介入。主要使用者包括大规模药物监测服务提供者、业务流程外包 (BPO) 公司和合约研究组织 (CRO)。推动市场发展的关键因素包括药物不良反应发生率的上升、外包机构对这些解决方案的日益普及以及监管机构对更安全药物的压力。

药物警戒与药物安全软体市场驱动因素

药物警戒和药物安全软体需求的不断增长，主要源自于全球卫生监管机构日益严格的监管。製药公司现在必须实施完善的不利事件报告和全面的药物安全监测，以确保合规性，这导致对可靠且扩充性的软体解决方案的需求持续增长。这些工具简化了复杂监管要求的管理，使公司能够执行安全通讯协定并维持高标准的药物相关问题监测。随着药物安全情势的不断演变，该领域高效软体解决方案对产业相关人员的重要性日益凸显。

药物安全检测与药物安全软体市场限制因素

将创新的药物监测和药物安全软体整合到现有系统和工作流程中往往面临许多挑战，并可能对营运造成重大干扰。平稳的资料迁移对于确保与原有系统的兼容性至关重要，因为原有系统可能不再像以前那样有效率。因此，由于这些新技术的高昂成本，企业在采用先进解决方案方面可能会面临延误。这些障碍会阻碍向更有效率系统的过渡，因为企业需要在现代化需求、预算限制以及整合新解决方案的复杂性之间寻求平衡。

药物警戒与药物安全软体市场趋势

人工智慧 (AI) 和机器学习技术的融合是药物警戒和药物安全软体市场的一大趋势。这种变革增强了数据分析能力，并实现了不利事件报告流程的自动化，从而提高了药物安全管理的效率和准确性。先进的预测分析技术使企业能够识别潜在的安全问题，并更好地遵守监管标准。因此，在快速发展的製药产业，各公司正加速采用这些创新解决方案，不仅是为了提高营运效率，更是为了保障病人安全和改善治疗效果。

The global market for pharmacovigilance and drug safety software is evolving to enhance the tracking, analysis, and reporting of adverse drug reactions (ADRs) and associated safety concerns. In Romania, these software solutions play a critical role in ensuring the safe and effective use of medications by monitoring their efficacy and side effects. They enable pharmaceutical companies, regulatory agencies, and healthcare professionals to efficiently collect, manage, and analyze extensive drug safety data, allowing for the identification of potential risks and trends to facilitate timely interventions. Primary users include large pharmacovigilance providers, BPOs, and contract research organizations (CROs). Key market drivers include the rising incidence of ADRs and the increasing adoption of these solutions by outsourcing organizations, alongside regulatory pressures for safer medications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmacovigilance and Drug Safety Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmacovigilance and Drug Safety Software Market Segments Analysis

Global Pharmacovigilance and Drug Safety Software Market is segmented by Function, Deployment Mode, End User and region. Based on Function, the market is segmented into Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software Based on Deployment Mode, the market is segmented into On Premise and Cloud. Based on end user, the market is segmented into Pharma and Biotech Companies, Contract Research Organizations, Business Process Outsourcing and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Pharmacovigilance and Drug Safety Software Market

The growing need for pharmacovigilance and drug safety software is primarily fueled by stringent global regulations imposed by various health authorities. Pharmaceutical companies are now required to conduct thorough adverse event reporting and implement comprehensive drug safety monitoring to ensure compliance, leading to an ongoing demand for dependable and scalable software solutions. These tools simplify the management of complex regulatory requirements, enabling firms to enhance their safety protocols and maintain high standards in monitoring drug-related issues. As the landscape of drug safety continues to evolve, the importance of effective software solutions in this area becomes increasingly critical for industry players.

Restraints in the Pharmacovigilance and Drug Safety Software Market

The integration of innovative pharmacovigilance and drug safety software with existing systems and workflows often presents significant challenges and can be quite disruptive. Ensuring smooth data migration is crucial for compatibility with older, more established systems, which may not function as effectively as they once did. Consequently, organizations may face delays in adopting advanced solutions, as the high costs associated with these new technologies can be prohibitive. These obstacles can hinder the transition to more efficient systems, as companies may struggle to balance the need for modernization with budgetary constraints and the complexities of integrating new solutions.

Market Trends of the Pharmacovigilance and Drug Safety Software Market

The pharmacovigilance and drug safety software market is experiencing a notable trend with the integration of artificial intelligence (AI) and machine learning technologies. This transformation enhances the capabilities of data analysis and allows for the automation of adverse event reporting processes, leading to more efficient and accurate drug safety management. With advanced predictive analytics, organizations are better equipped to identify potential safety issues and comply with regulatory standards. As a result, companies are increasingly adopting these innovative solutions to not only streamline their operations but also to improve patient safety and outcomes in a rapidly evolving pharmaceutical landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Trade Analysis
Startup Analysis
Supply Chain Analysis
Pricing Analysis

Global Pharmacovigilance and Drug Safety Software Market Size by Function & CAGR (2026-2033)

Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

Global Pharmacovigilance and Drug Safety Software Market Size by Deployment Mode & CAGR (2026-2033)

On Premise
On Cloud

Global Pharmacovigilance and Drug Safety Software Market Size by End User & CAGR (2026-2033)

Pharma and Biotech Companies
Contract Research Organizations
Business Process Outsourcing
Other

Global Pharmacovigilance and Drug Safety Software Market Size & CAGR (2026-2033)

North America, (Function, Deployment Mode, End User)
- US
- Canada
Europe, (Function, Deployment Mode, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Function, Deployment Mode, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Function, Deployment Mode, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Function, Deployment Mode, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veeva Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB-Cube
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArisGlobal
- Company Overview
- Business Segment Overview